Suppr超能文献

生物制药生产的制造、监管及商业挑战:芬兰视角

Manufacturing, regulatory and commercial challenges of biopharmaceuticals production: a Finnish perspective.

作者信息

Närhi Marko, Nordström Katrina

机构信息

Department of Chemical Technology, Laboratory of Biochemistry and Microbiology, Helsinki University of Technology, Espoo, Finland.

出版信息

Eur J Pharm Biopharm. 2005 Apr;59(3):397-405. doi: 10.1016/j.ejpb.2004.11.006.

Abstract

Biopharmaceuticals product development is a broad and multidisciplinary field. Science and technology are combined with new manufacturing, regulatory and commercial challenges. However, although there is ample literature on the molecular biology and biochemistry of products, the implementation of processes from test tube to commercial scale has not received similar attention. Consequently, the present study aims to highlight, from practical point of view, some of the key issues involved with manufacturing technologies of biopharmaceuticals at a commercial scale. Regulatory requirements and investments are also addressed based on the practical experiences of start-up and small companies. Finland is used as a case-example of such companies as this is a EU-member state with strong technological growth and rapidly increasing number of biotech companies.

摘要

生物制药产品开发是一个广泛的多学科领域。科学技术与新的制造、监管和商业挑战相结合。然而,尽管关于产品的分子生物学和生物化学有大量文献,但从试管到商业规模的工艺实施却没有受到同样的关注。因此,本研究旨在从实际角度突出商业规模生物制药制造技术所涉及的一些关键问题。还将根据初创公司和小公司的实际经验探讨监管要求和投资问题。芬兰被用作这类公司的一个案例,因为它是一个技术增长强劲且生物技术公司数量迅速增加的欧盟成员国。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验